Allegion (ALLE) CFO exercises options, sells 3,184 shares in 10b5-1 trades

Q: What did Allegion (ALLE) SVP and CFO Michael J. Wagnes report in this Form 4?

Michael J. Wagnes reported option exercises and share sales in Allegion plc stock. He exercised options for 1,716 and 1,468 shares, then sold the same numbers of ordinary shares on July 23, 2026 , all under a pre-established Rule 10b5-1 plan.

Q: How many Allegion (ALLE) shares did Michael J. Wagnes sell and at what price?

Michael J. Wagnes sold a total of 3,184 ordinary shares of Allegion plc, consisting of 1,716 and 1,468 shares. Both sale transactions were executed at a price of $150.98 per share on July 23, 2026, according to the Form 4 data.

Q: What stock options did Michael J. Wagnes exercise in Allegion (ALLE)?

He exercised two sets of stock options converting into ordinary shares. One covered 1,716 shares at an exercise price of $71.835 with expiration February 13, 2027. The other covered 1,468 shares at an exercise price of $86.93 with expiration February 22, 2028.

Q: Were the Allegion (ALLE) transactions by Michael J. Wagnes under a Rule 10b5-1 plan?

Yes. Footnotes state that both the option exercises and the share sales were effected pursuant to a Rule 10b5-1 trading plan. This plan was adopted by Michael J. Wagnes on September 12, 2025 , providing a pre-arranged framework for these trades.

Q: What role does Michael J. Wagnes hold at Allegion (ALLE) in this Form 4?

Michael J. Wagnes is identified as Allegion plc’s Senior Vice President and Chief Financial Officer . The Form 4 reports his personal transactions in Allegion securities, including option exercises and subsequent sales of ordinary shares executed on July 23, 2026.

Q: What are the vesting details of the Allegion (ALLE) options exercised by Michael J. Wagnes?

The options for 1,716 shares vested in equal annual installments on February 13, 2018, 2019, and 2020. The options for 1,468 shares vested in equal annual installments on February 22, 2019, 2020, and 2021, and were exercisable at the reported dates.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Allegion plc SVP and CFO Michael J. Wagnes exercised stock options for 1,716 shares at $71.835 and 1,468 shares at $86.93, receiving the same number of ordinary shares. He then sold 1,716 and 1,468 ordinary shares at $150.98 per share. All exercises and sales were executed under a Rule 10b5-1 trading plan adopted on September 12, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 3,184 shares ($230K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Wagnes Michael J.

Role SVP and CFO

Sold 3,184 shs ($481K)

Approx. gross sale proceeds $481K

Approx. exercise cost $251K

Approx. pre-tax spread $230K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^{F1, F3}	1,716	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F4}	1,468	$0.00	$0.00
Exercise	Ordinary Shares ^F1	1,716	$71.835	$123K
Sale	Ordinary Shares ^F2	1,716	$150.98	$259K
Exercise	Ordinary Shares ^F1	1,468	$86.93	$128K
Sale	Ordinary Shares ^F2	1,468	$150.98	$222K

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Ordinary Shares — 31,299 shares (Direct)

Footnotes (4)

F1. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
F3. A stock option that vested in equal annual installments on February 13, 2018, February 13, 2019, and February 13, 2020, and is exercisable.
F4. A stock option that vested in equal annual installments on February 22, 2019, February 22, 2020, and February 22, 2021, and is exercisable.

Key Figures

Options exercised 1: 1,716 shares at $71.835 Options exercised 2: 1,468 shares at $86.93 Shares sold 1: 1,716 shares at $150.98 +2 more

5 metrics

Options exercised 1 1,716 shares at $71.835 Stock option (right to buy) converting into ordinary shares on July 23, 2026

Options exercised 2 1,468 shares at $86.93 Stock option (right to buy) converting into ordinary shares on July 23, 2026

Shares sold 1 1,716 shares at $150.98 Sale of ordinary shares on July 23, 2026

Shares sold 2 1,468 shares at $150.98 Sale of ordinary shares on July 23, 2026

10b5-1 plan adoption date September 12, 2025 Date Michael J. Wagnes adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy, Ordinary Shares, Exercise or conversion of derivative security

4 terms

Rule 10b5-1 trading plan regulatory

"The option exercises reported were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy financial

"security_title: Stock Option (Right to Buy) with specified exercise prices"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares received upon option exercise"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/27/2026 - 04:12 PM Accepted by SEC EDGAR 07/27/2026 - 04:12 PM

FAQ

What did Allegion (ALLE) SVP and CFO Michael J. Wagnes report in this Form 4?

Michael J. Wagnes reported option exercises and share sales in Allegion plc stock. He exercised options for 1,716 and 1,468 shares, then sold the same numbers of ordinary shares on July 23, 2026, all under a pre-established Rule 10b5-1 plan.

How many Allegion (ALLE) shares did Michael J. Wagnes sell and at what price?

Michael J. Wagnes sold a total of 3,184 ordinary shares of Allegion plc, consisting of 1,716 and 1,468 shares. Both sale transactions were executed at a price of $150.98 per share on July 23, 2026, according to the Form 4 data.

What stock options did Michael J. Wagnes exercise in Allegion (ALLE)?

He exercised two sets of stock options converting into ordinary shares. One covered 1,716 shares at an exercise price of $71.835 with expiration February 13, 2027. The other covered 1,468 shares at an exercise price of $86.93 with expiration February 22, 2028.

Were the Allegion (ALLE) transactions by Michael J. Wagnes under a Rule 10b5-1 plan?

Yes. Footnotes state that both the option exercises and the share sales were effected pursuant to a Rule 10b5-1 trading plan. This plan was adopted by Michael J. Wagnes on September 12, 2025, providing a pre-arranged framework for these trades.

What role does Michael J. Wagnes hold at Allegion (ALLE) in this Form 4?

Michael J. Wagnes is identified as Allegion plc’s Senior Vice President and Chief Financial Officer. The Form 4 reports his personal transactions in Allegion securities, including option exercises and subsequent sales of ordinary shares executed on July 23, 2026.

What are the vesting details of the Allegion (ALLE) options exercised by Michael J. Wagnes?

The options for 1,716 shares vested in equal annual installments on February 13, 2018, 2019, and 2020. The options for 1,468 shares vested in equal annual installments on February 22, 2019, 2020, and 2021, and were exercisable at the reported dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagnes Michael J.

(Last)

(First)

(Middle)

C/O SCHLAGE LOCK COMPANY LLC

11819 N. PENNSYLVANIA STREET

(Street)

CARMEL

INDIANA

46032

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Allegion plc [ ALLE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	07/23/2026		M⁽¹⁾		1,716	A	$71.835	33,015	D
Ordinary Shares	07/23/2026		S⁽²⁾		1,716	D	$150.98	31,299	D
Ordinary Shares	07/23/2026		M⁽¹⁾		1,468	A	$86.93	32,767	D
Ordinary Shares	07/23/2026		S⁽²⁾		1,468	D	$150.98	31,299	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$71.835	07/23/2026		M⁽¹⁾			1,716	⁽³⁾	02/13/2027	Ordinary Shares	1,716	$0	0	D
Stock Option (Right to Buy)	$86.93	07/23/2026		M⁽¹⁾			1,468	⁽⁴⁾	02/22/2028	Ordinary Shares	1,468	$0	0	D

Explanation of Responses:

1. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

3. A stock option that vested in equal annual installments on February 13, 2018, February 13, 2019, and February 13, 2020, and is exercisable.

4. A stock option that vested in equal annual installments on February 22, 2019, February 22, 2020, and February 22, 2021, and is exercisable.

Remarks:

	/s/ Tandra M. Foster, Attorney-In-Fact	07/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR